Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Pacific Biosciences (PACB)

Pacific Biosciences (PACB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 468,430
  • Shares Outstanding, K 272,343
  • Annual Sales, $ 200,520 K
  • Annual Income, $ -306,740 K
  • 60-Month Beta 1.99
  • Price/Sales 2.28
  • Price/Cash Flow N/A
  • Price/Book 0.76
Trade PACB with:

Options Overview Details

View History
  • Implied Volatility 150.29% ( -0.36%)
  • Historical Volatility 217.38%
  • IV Percentile 98%
  • IV Rank 90.86%
  • IV High 160.37% on 04/17/24
  • IV Low 50.05% on 09/01/23
  • Put/Call Vol Ratio 0.45
  • Today's Volume 1,016
  • Volume Avg (30-Day) 3,542
  • Put/Call OI Ratio 0.29
  • Today's Open Interest 96,844
  • Open Int (30-Day) 79,775

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.26
  • Number of Estimates 3
  • High Estimate -0.24
  • Low Estimate -0.27
  • Prior Year -0.31
  • Growth Rate Est. (year over year) +16.13%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.2500 +37.60%
on 04/17/24
3.5000 -50.86%
on 04/10/24
-1.8900 (-52.35%)
since 04/09/24
3-Month
1.2500 +37.60%
on 04/17/24
6.8300 -74.82%
on 02/15/24
-4.9200 (-74.10%)
since 02/09/24
52-Week
1.2500 +37.60%
on 04/17/24
14.5500 -88.18%
on 07/18/23
-10.3100 (-85.70%)
since 05/09/23

Most Recent Stories

More News
Pacific Biosciences: Q1 Earnings Snapshot

Pacific Biosciences: Q1 Earnings Snapshot

PACB : 1.7200 (+2.38%)
Pacific Biosciences: Q4 Earnings Snapshot

Pacific Biosciences: Q4 Earnings Snapshot

PACB : 1.7200 (+2.38%)
Pacific Biosciences: Q3 Earnings Snapshot

Pacific Biosciences: Q3 Earnings Snapshot

PACB : 1.7200 (+2.38%)
Cathie Wood Just Added $5 Million of This Stock After It Had a Steep Pullback. Is It a No-Brainer Buy?

This innovator is targeting a huge, rapidly growing market.

PACB : 1.7200 (+2.38%)
ARKK : 44.16 (-0.61%)
ARKG : 25.09 (+1.87%)
PacBio Announces Appointment of David Meline to Board of Directors

/PRNewswire/ -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the appointment of David...

PACB : 1.7200 (+2.38%)
PacBio to Report Third Quarter 2023 Financial Results on October 30, 2023

/PRNewswire/ -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its third quarter 2023 financial results on...

PACB : 1.7200 (+2.38%)
PacBio Announces Complete Computational Workflow for Human Whole Genome Sequencing Data Analysis

/PRNewswire/ -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the availability of PacBio...

PACB : 1.7200 (+2.38%)
Cathie Wood's Buying These 3 Stocks Hand Over Fist

A drugmaker, a gene sequencer, and a streaming business all made deep impressions on Ark Invest's stock-picking team.

AAPL : 184.57 (+1.00%)
ILMN : 111.35 (+0.66%)
BEAM : 22.54 (+1.35%)
PACB : 1.7200 (+2.38%)
SPOT : 298.66 (unch)
PacBio Announces Collaboration with Leading Library Preparation Automation Partners

/PRNewswire/ -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced that automation providers...

PACB : 1.7200 (+2.38%)
PacBio to Present at Upcoming Investor Conferences

/PRNewswire/ -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will be...

PACB : 1.7200 (+2.38%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Pacific Biosciences of California Inc., popularly known as PacBio, develops, manufactures and markets sequencing systems, which help in studying synthesis, composition, structure and regulation of deoxyribonucleic acid, popularly known as DNA. PacBio's products are based on Single Molecule, Real-Time...

See More

Key Turning Points

3rd Resistance Point 1.8850
2nd Resistance Point 1.8400
1st Resistance Point 1.7800
Last Price 1.7200
1st Support Level 1.6750
2nd Support Level 1.6300
3rd Support Level 1.5700

See More

52-Week High 14.5500
Fibonacci 61.8% 9.4694
Fibonacci 50% 7.9000
Fibonacci 38.2% 6.3306
Last Price 1.7200
52-Week Low 1.2500

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar